基层医学论坛
基層醫學論罈
기층의학론단
The Medical Forum
2015年
31期
4321-4322
,共2页
王曼曼%穆攀伟%陈宣蓉%舒冏%陈燕铭%曾龙驿
王曼曼%穆攀偉%陳宣蓉%舒冏%陳燕銘%曾龍驛
왕만만%목반위%진선용%서경%진연명%증룡역
2型糖尿病%血清胱抑素C%320-DVCT%冠状动脉病变支数%相关性
2型糖尿病%血清胱抑素C%320-DVCT%冠狀動脈病變支數%相關性
2형당뇨병%혈청광억소C%320-DVCT%관상동맥병변지수%상관성
Type 2 diabetes mellitus%Serum cystatin C%320-DVCT%Coronary artery disease number%Correlation
目的:探讨新诊断2型糖尿病患者血清胱抑素C(CysC)与冠状动脉病变支数的关系。方法2009年—2012年在我院内分泌科住院的新诊断2型糖尿病患者64例,根据320-DVCT中冠状动脉病变支数将患者分为3组:无病变组(A组,n=16)、单支病变组(B组,n=21)、多支病变组(C组,n=27)。比较3组间血清CysC的差异。结果血清CysC在A、B、C组分别是(0.62±0.28)mg/L、(1.16±0.50)mg/L、(1.52±0.69)mg/L,3组血清CysC水平有显著性差异(P<0.05)。结论新诊断2型糖尿病患者血清CysC水平与冠状动脉病变支数间呈正相关。
目的:探討新診斷2型糖尿病患者血清胱抑素C(CysC)與冠狀動脈病變支數的關繫。方法2009年—2012年在我院內分泌科住院的新診斷2型糖尿病患者64例,根據320-DVCT中冠狀動脈病變支數將患者分為3組:無病變組(A組,n=16)、單支病變組(B組,n=21)、多支病變組(C組,n=27)。比較3組間血清CysC的差異。結果血清CysC在A、B、C組分彆是(0.62±0.28)mg/L、(1.16±0.50)mg/L、(1.52±0.69)mg/L,3組血清CysC水平有顯著性差異(P<0.05)。結論新診斷2型糖尿病患者血清CysC水平與冠狀動脈病變支數間呈正相關。
목적:탐토신진단2형당뇨병환자혈청광억소C(CysC)여관상동맥병변지수적관계。방법2009년—2012년재아원내분비과주원적신진단2형당뇨병환자64례,근거320-DVCT중관상동맥병변지수장환자분위3조:무병변조(A조,n=16)、단지병변조(B조,n=21)、다지병변조(C조,n=27)。비교3조간혈청CysC적차이。결과혈청CysC재A、B、C조분별시(0.62±0.28)mg/L、(1.16±0.50)mg/L、(1.52±0.69)mg/L,3조혈청CysC수평유현저성차이(P<0.05)。결론신진단2형당뇨병환자혈청CysC수평여관상동맥병변지수간정정상관。
ObjectiveTo investigate the relationship between serum cystatin C(CysC)and the number of diseased coronary artery in newly diagnosed type 2 diabetes mellitus(T2DM)patients.MethodsAccording to the number of diseased coronary artery measured by 320-DVCT,a total of 64 newly diagnosed T2DM patients visited in our department of endocrinology from 2009 to 2012 were divided into three groups:no coronary artery lesion group (group A, n=16),one coronary artery lesion group(group B,n=21),multiple coronary artery lesion group(group C,n=27). CysC were compared.ResultsSerum CysC in A,B,C group were(0.62±0.28)mg/L,(1.16±0.50)mg/L,(1.52±0.69) mg/L. There were significant difference among the groups(P<0.05).ConclusionsThere was a significantly positive correlation between serum cystatin C and the number of diseased coronary artery in newly diagnosed T2DM patients.